Randomized, Prospective Comparison of the Outcome of Toric Implantable Contact Lens (TICL) and Q-LASIK for the Correction of Myopia With Astigmatism

Sponsor
Wenzhou Medical University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01088568
Collaborator
Staar Surgical Company (Industry)
30
1
2
28
1.1

Study Details

Study Description

Brief Summary

The objective is to conduct a contralateral prospective clinical study to compare the safety, efficacy, and quality of vision of the STAAR Surgical Co. Toric Implantable Contact Lens TICL) versus Custom Laser Vision Correction (Q-LASIK) in human eyes for the correction of myopia with astigmatism.

Condition or Disease Intervention/Treatment Phase
  • Procedure: the implantation of toric implantable collamer lens
  • Procedure: customized laser-assisted in situ keratomileusis
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized, Prospective Comparison of the Outcome of TICL and Q Value Customized LASIK for the Correction of Myopia With Astigmatism
Study Start Date :
Nov 1, 2007
Actual Primary Completion Date :
Dec 1, 2008
Anticipated Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: TICL group

Procedure: the implantation of toric implantable collamer lens
perform the implantation of toric implantable collamer lens for both eyes
Other Names:
  • TICL
  • Active Comparator: LASIK group

    Procedure: customized laser-assisted in situ keratomileusis
    perform Q-factor customized laser-assisted in situ keratomileusis for both eyes
    Other Names:
  • Q-factor customized LASIK
  • Outcome Measures

    Primary Outcome Measures

    1. Comparing the efficacy, predictability, stability and safety of TICL versus Q-LASIK [1week, 1,3,6 months]

    Secondary Outcome Measures

    1. Comparing wavefront aberrometry of TICL vs Q-LASIK Comparing contrast sensitivity of TICL vs Q-LASIK Comparing patient satisfaction of TICL vs Q-LASIK [1, 3, 6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age: 21-45 years old

    • Documented stable refraction for at least 1 year

    • (-3.0 to -8.0D of myopia with -1.0 to -4.0D of astigmatism or SE from -3.5 to -10D

    • BSCVA: 20/20 or better

    • Pupil diameter: smaller than 7mm under mesopic condition

    • Contact lens discontinued 3 weeks and 1 week for hard and soft wearers respectively

    Exclusion Criteria:
    • Evidence of progressive or acute disease

    • Evidence of connective tissue disease or clinically significant atopic disease

    • ACD less than 2.8mm from endothelium

    • ECC less than 2200 cells/mm2

    • Narrow angle of anterior chamber

    • Residual stromal thickness less than 280 microns

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Eye hospital of Wenzhou Medical College Wenzhou Zhejiang China 325027

    Sponsors and Collaborators

    • Wenzhou Medical University
    • Staar Surgical Company

    Investigators

    • Study Director: Qin Mei Wang, Eye hospital of Wenzhou Medical College

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01088568
    Other Study ID Numbers:
    • 20091231
    First Posted:
    Mar 17, 2010
    Last Update Posted:
    Mar 17, 2010
    Last Verified:
    Oct 1, 2009

    Study Results

    No Results Posted as of Mar 17, 2010